Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictor

This publication has 11 references indexed in Scilit:

• Phase II Trial of High-Dose Cisplatin plus Etoposide plus Vinblastine in Non-Small-Cell Lung Cancer
  American Journal of Clinical Oncology, 1991
• A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
  Journal of Clinical Oncology, 1991
• A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
  Journal of Clinical Oncology, 1991
• Role of systemic therapy in advanced non-small-cell lung cancer
  The American Journal of Medicine, 1990
• A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1990
• Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial.
  Journal of Clinical Oncology, 1990
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
  Journal of Clinical Oncology, 1988
• The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0)
  The Annals of Thoracic Surgery, 1988
• Measurability of non-small-cell lung cancer on chest radiographs.
  Journal of Clinical Oncology, 1986
• A computer program for comparing K samples with right-censored data
  Computer Programs in Biomedicine, 1972